Search for: "Sanofi-Aventis" Results 101 - 120 of 561
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jan 2011, 10:38 am by CorporateAcquisitions MergerLawBlogger
So says Reuters: U.S. biotech company Genzyme Corp and French drugmaker Sanofi-Aventis SA have reached an agreement in principle on the outlines of a merger deal, three sources familiar with the situation said on Monday. [read post]
24 Oct 2008, 12:09 pm
Trista Kelley from Bloomberg.com reports this morning that European regulators have pulled Sanofi-Aventis, SA's obesity pill, Acomplia, citing concerns about its side effects. [read post]
28 Mar 2007, 7:44 pm
By Jason Derry --- Sanofi-Aventis and Oxford BioMedica have announced an agreement under which the two companies will jointly develop and market TroVax ® for treating and preventing cancer. [read post]
12 Nov 2009, 3:02 am
The top executive of French drug maker Sanofi-Aventis reached out to Boston-area researchers and biotechnology start-ups, offering "partnerships for innovation" that could range from investing in drugs to outright acquisitions, The Boston Globe reported. [read post]
8 Sep 2010, 2:37 am by By DEALBOOK
Sanofi-Aventis's chief executive Chris Viehbacher took his case for a takeover directly to Genzyme's investors in meetings in New York Tuesday, Bloomberg News reported, citing two people who attended. [read post]
29 Sep 2010, 2:24 am by By DEALBOOK
Genzyme's chief executive, Henri Termeer, has suggested he is more open Sanofi-Aventis's proposed takeover of the biotechnology company than at any point in the past, telling The Financial Times, he would be prepared step down to facilitate the deal. [read post]
27 Sep 2010, 4:19 am by By DEALBOOK
Sanofi-Aventis is looking to line up additional financing as it mulls upping its bid for Genzyme, The Wall Street Journal reported. [read post]
1 Jun 2009, 9:03 pm
Sanofi-Aventis bought BiPar to obtain rights to BiPar's BSI-201, which belongs to a new class of drugs that block a cell repair enzyme known as PARP. [read post]
21 Jun 2007, 5:49 am
Via Reuters:Switzerland has recommended that girls should be vaccinated with Gardasil, the cervical cancer shot marketed by Merck Co Inc (MRK.N: Quote, Profile, Research) and Sanofi-Aventis SA (SASY.PA: Quote, Profile, Research) in Europe, the firms said on Monday. [read post]
1 Apr 2007, 7:20 am
KETEK (telithromycin), manufactured and sold by Sanofi-aventis U.S. recently decided, after prompting by the U.S. [read post]
4 Feb 2023, 5:28 pm by Ron Coleman
Per the EFF, Sanofi-Aventis backed down: “Under terms of Tuesday’s settlement, AcompliaReport.com keeps its domain name, as long as there is a disclaimer stating... [read post]
9 Jun 2008, 4:50 am
Sanofi-Aventis Deutschland GMBH et al. 2:08-cv-00258; filed June 5, 2008 in the Eastern District of Virginia Declaratory judgment of non-infringement and invalidity of U.S. [read post]
6 Jan 2017, 6:04 pm by Michael Baseluos
The FDA  found Sanofi Aventis in violation of the Federal Food, Drug, and Cosmetic Act. [read post]
6 Jan 2017, 6:04 pm by Michael Baseluos
The FDA  found Sanofi Aventis in violation of the Federal Food, Drug, and Cosmetic Act. [read post]
28 Apr 2015, 2:36 am by Mark Summerfield
A court ruling has revealed that the Commonwealth of Australia (i.e. the Federal Government) is seeking to recover $60 million it considers has been ‘overpaid’ for the anti-clotting drug marketed by Sanofi (formerly Sanofi-Aventis) and Bristol-Meyers Squibb under the brand name PLAVIX: Commonwealth of Australia v Sanofi-Aventis [2015] FCA 384.Sanofi was the owner of Australian Patent No. 597784, which includes claims directed to the… [read post]
16 Jul 2010, 2:44 pm
On July 13, 2010, the Food and Drug Administration reported in a drug safety alert, that it is requiring Sanofi-Aventis to place a black box warning on its rheumatoid arthritis drug, Arava. [read post]
3 Aug 2010, 9:47 pm by Patent Docs
Noonan -- Last Friday, sanofi-aventis and Microsoft joined in filing an amicus curiae brief with the Federal Circuit in the Therasense, Inc. v. [read post]